407 related articles for article (PubMed ID: 18057471)
1. [The use of methylphenidate in children with ADHD].
Lauth B
Laeknabladid; 2007 Dec; 93(12):823. PubMed ID: 18057471
[No Abstract] [Full Text] [Related]
2. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
3. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
Janols LO; Liliemark J; Klintberg K; von Knorring AL
Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
[TBL] [Abstract][Full Text] [Related]
4. ADHD drugs and cardiovascular risk.
Wojnowski L
N Engl J Med; 2006 May; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729376
[No Abstract] [Full Text] [Related]
5. [Central stimulants in the treatment of children with ADHD: unknown long-term effect and uncertain pharmacological documentation].
Zetterström R
Lakartidningen; 2002 Feb; 99(7):677-80. PubMed ID: 11887717
[No Abstract] [Full Text] [Related]
6. The stimulants.
Wilens TE; Biederman J
Psychiatr Clin North Am; 1992 Mar; 15(1):191-222. PubMed ID: 1347939
[TBL] [Abstract][Full Text] [Related]
7. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
't Jong GW; van den Anker JN
Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
[No Abstract] [Full Text] [Related]
8. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
9. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
[No Abstract] [Full Text] [Related]
10. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
[TBL] [Abstract][Full Text] [Related]
11. Attention-deficit-hyperactivity disorder.
Diller LH
N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
[No Abstract] [Full Text] [Related]
12. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
Shalev R; Gross-Tsur V
Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
[No Abstract] [Full Text] [Related]
13. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
Fogelman Y; Kahan E
Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
Gadow KD; Sverd J
Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
[No Abstract] [Full Text] [Related]
15. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
16. Attention-deficit/hyperactivity disorder: a personal perspective.
Ginsberg ML
Adolesc Med State Art Rev; 2008 Aug; 19(2):339-51, xi-xii. PubMed ID: 18822837
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
Gumy C; Huissoud T; Dubois-Arber F
J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
[TBL] [Abstract][Full Text] [Related]
18. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
19. Neurogenetic determinism and the new euphenics. Child and adolescent psychiatrists use methylphenidate because it makes children better.
Williams JH
BMJ; 1999 May; 318(7196):1488-9. PubMed ID: 10419301
[No Abstract] [Full Text] [Related]
20. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
